These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 9462168
1. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation. Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, Kallenberg CG. Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168 [Abstract] [Full Text] [Related]
5. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A. PLoS One; 2013 Nov; 8(8):e71458. PubMed ID: 23951169 [Abstract] [Full Text] [Related]
6. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Arthritis Rheum; 1990 May; 33(5):634-43. PubMed ID: 2346519 [Abstract] [Full Text] [Related]
9. Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus. Vlachoyiannopoulos PG, Guialis A, Tzioufas G, Moutsopoulos HM. Br J Rheumatol; 1996 Jun; 35(6):534-41. PubMed ID: 8670573 [Abstract] [Full Text] [Related]
10. A cross-sectional study of anti-DNA antibodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives. Williams WM, Isenberg DA. Lupus; 1996 Dec; 5(6):576-86. PubMed ID: 9116700 [Abstract] [Full Text] [Related]
12. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients. Hylkema MN, van Bruggen MC, ten Hove T, de Jong J, Swaak AJ, Berden JH, Smeenk RJ. J Autoimmun; 2000 Mar; 14(2):159-68. PubMed ID: 10677247 [Abstract] [Full Text] [Related]
13. Antibody clustering helps refine lupus prognosis. Kessel A, Rosner I, Halasz K, Grushko G, Shoenfeld Y, Paran D, Toubi E. Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829 [Abstract] [Full Text] [Related]
14. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Kim KH, Han JY, Kim JM, Lee SW, Chung WT. Clin Chim Acta; 2007 May 01; 380(1-2):182-5. PubMed ID: 17355877 [Abstract] [Full Text] [Related]
15. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Spronk PE, Horst G, Van Der Gun BT, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1996 Jun 01; 104(3):446-53. PubMed ID: 9099929 [Abstract] [Full Text] [Related]
16. Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. Tzioufas AG, Manoussakis MN, Drosos AA, Silis G, Gharavi AE, Moutsopoulos HM. Clin Exp Rheumatol; 1987 Jun 01; 5(3):247-53. PubMed ID: 3501355 [Abstract] [Full Text] [Related]
17. Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS). Ehrenstein MR, Swana M, Keeling D, Asherson R, Hughes GR, Isenberg DA. Br J Rheumatol; 1993 May 01; 32(5):362-5. PubMed ID: 8495254 [Abstract] [Full Text] [Related]
18. The use of laboratory tests in the diagnosis of SLE. Egner W. J Clin Pathol; 2000 Jun 01; 53(6):424-32. PubMed ID: 10911799 [Abstract] [Full Text] [Related]
19. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. Neogi T, Gladman DD, Ibanez D, Urowitz M. J Rheumatol; 2006 Sep 01; 33(9):1785-8. PubMed ID: 16924691 [Abstract] [Full Text] [Related]